Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma

Table 1 Clinical characteristics of patients with benign biliary tract diseases (control) and cholangiocarcinoma

	Control	Cholangiocarcinoma	P
	n = 128	n = 59
Age (yr)	61 ± 7	67 ± 5	0.451
Sex (M:F)	62:66	36:23	0.118
Albumin (mg/dL)	3.9 ± 0.67	3.1 ± 0.59	< 0.001
Globulin (mg/dL)	3.9 ± 0.72	4.1 ± 0.91	0.073
Total bilirubin (mg/dL)	3.3 ± 3.71	12.0 ± 11.35	< 0.001
AST (U/L)	73.4 ± 78.14	91.2 ± 75.91	0.003
ALT (U/L)	76.3 ± 83.32	52.2 ± 43.58	0.884
ALP (U/L)	320.3 ± 230.03	380.5 ± 314.52	< 0.001

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase.